Company Analysis

Alzamend Neuro, Inc. (ALZN)

Nasdaq: ALZN · Pharmaceutical Preparations · Atlanta, GA · filing with the SEC since 2016
Grade4.3
◀ Past 3.4● Present 3.8▶ Future 5.3
6 est.

Filings

212 filings since 2017 beside 172 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Oct 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Dec 15, 2026
10-K Annual report for the fiscal year ending Apr 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Jul 29, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Feb 26, 2026.

Filings a yearinsider forms included
911978136575433
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Aug 3, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest May 9, 2024.Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Jan 5, 2024.SEC letters: 7 in the last 36 months, the newest Apr 4, 2025.A late-filing notice, Form NT 10-K, filed Jul 30, 2024.A late-filing notice, Form NT 10-Q, filed Mar 18, 2024.
Insider forms 172

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 8-K/A items 1.01, 3.02, 5.03, 9.01 Major agreement signed; Shares sold without registration; Charter, bylaw or fiscal-year change · Current report, amended Aug 3, 2026
Oct 9, 2026 RW Registration withdrawal request
Sep 29, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 10, 2026 10-Q Quarterly report Jul 31, 2026
Aug 28, 2026 PRE 14A Preliminary proxy statement Oct 19, 2026
Aug 21, 2026 S-1 Listing registration
Jul 22, 2026 10-K Annual report Apr 30, 2026
Jul 21, 2026 8-K items 8.01, 9.01 Other event · Current report
Apr 17, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report
Mar 20, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report
Mar 11, 2026 10-Q Quarterly report Jan 31, 2026
Mar 6, 2026 424B5 Shelf offering
Mar 6, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Feb 26, 2026 DEFA14A Extra proxy material
Feb 26, 2026 DEF 14A Proxy statement Apr 17, 2026
Feb 9, 2026 PRE 14A Preliminary proxy statement Apr 17, 2026
Dec 9, 2025 10-Q Quarterly report Oct 31, 2025
Nov 18, 2025 8-K items 8.01, 9.01 Other event · Current report
Oct 14, 2025 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report
Oct 9, 2025 8-K items 3.02, 9.01 Shares sold without registration · Current report
Oct 7, 2025 SCHEDULE 13D/A Activist holder update, amended
Oct 3, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 30, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 25, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 25, 2025 8-K items 3.02, 9.01 Shares sold without registration · Current report
Sep 23, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 10, 2025 10-Q Quarterly report Jul 31, 2025
Aug 1, 2025 SCHEDULE 13D/A Activist holder update, amended
Aug 1, 2025 8-K items 3.02, 9.01 Shares sold without registration · Current report
Jul 23, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 22, 2025 10-K Annual report Apr 30, 2025
Jul 9, 2025 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report
May 8, 2025 8-K items 5.03, 7.01, 9.01 Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Apr 25, 2025 8-K items 5.07, 9.01 Shareholder vote · Current report
Apr 9, 2025 424B3 Shelf offering
Apr 8, 2025 EFFECT Registration effective
Apr 4, 2025 CORRESP Reply to the SEC
Mar 27, 2025 S-1/A Listing registration, amended
Mar 21, 2025 UPLOAD SEC comment letter
40 of 212 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ALZN · research, not advice